Intellectual Property India Publishes Patent Application for '5-Ht2a Receptor Inverse Agonist, And Preparation Method Therefor And Use Thereof' Filed by Luye Innomind Pharma Shijiazhuang Co. Ltd.

MUMBAI, India, March 7 -- Intellectual Property India has published a patent application (202527008497 A) filed by Luye Innomind Pharma Shijiazhuang Co. Ltd., Hebei, China, on Feb. 1, for '5-ht2a receptor inverse agonist, and preparation method therefor and use thereof.'

Inventor(s) include Tian, Jingwei; Ye, Liang; Ma, Mingxu; Wang, Wenyan; Du, Guangying; Zhang, Jianzhao; Dai, Yusen; and Zhang, Rui.

The application for the patent was published on March 7, under issue no. 10/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to a new compound as a 5-HT2A receptor inverse agonist, a preparation method therefor and a pharmaceutical composition. The present invention further relates t...